Grants and Contributions:
Title:
Development of scalable manufacturing processes for a novel 3D Bioprinter Platform
Agreement Number:
893045
Agreement Value:
$446,300.00
Agreement Date:
Dec 1, 2017 - Apr 30, 2019
Description:
This project involves the development of scalable manufacturing processes and improved automation systems for the firm's novel microfluidics-based 3D bioprinter platform that are necessary for the successful and profitable commercial launch of the bioprinter and associated consumables.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6P 6P2
Reference Number:
172-2018-2019-Q4-893045
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
830167839
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 2 time(s). The end date of this agreements has been modified by 151 days. The total amended value is 110,300 dollars.
Amendment Date
Mar 29, 2019
Recipient's Legal Name:
Aspect Biosystems Ltd.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: